Archives

by in
Entry Author Date Location
Ophthotech, Novartis Team up on $1B Deal for Eye Drug 05/19/14 New York
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Kala Pharmaceuticals Secures $22,500,000 Series B Financing Round 04/23/14 Boston
Ophthotech Prices IPO at $22 Per Share, Reels in $167M 09/24/13 New York
Ophthotech Eyes $85M IPO With Late-Stage Clinical Trial in Sight 08/15/13 New York
Ophthotech Nabs $175M To Fund Late-Stage Trial For Eye Drug 05/29/13 New York
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist 03/01/13 Boston
Kala Pharmaceuticals Receives $11,500,000 Series A Funding Round 03/01/13 Boston
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs 02/28/13 Boston
Kala, ImmunoGen, Boring Biotech, & More Boston Life Sciences News 07/13/12 Boston
Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug 03/23/12 Boston
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases 03/19/12 Boston
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
Kala Pharmaceuticals Lands $6,200,000 Seed Round 03/14/12 Boston
The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra 04/19/11 Boston
EMC Shells Out $2.25B for Isilon, Cerulean Secures $24M, Kayak Files for IPO, & More Boston-Area Deals News 11/18/10 Boston
$3M for Kala Pharmaceuticals 11/12/10 Boston
Kala Pharmaceuticals Garners $3,000,000 New Financing Round 11/10/10 Boston
The Boston Deals You Missed During the Holidays: Cash for Kala Pharma, Funds for ViewFinity, Silver for SCVNGR, & More 01/04/10 Boston
Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M 12/23/09 Boston
Page 1 of 1